According to the new market research report" Women’s Health Diagnostics Market by Application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021", published by MarketsandMarkets™,The global women’s health diagnostics market is projected to reach USD 36.64 Billion by 2021 from USD 25.03 Billion in 2016, at a CAGR of around 7.9% during the forecast period.

Factors such as growing awareness about various health-related disorders among women, rising incidence of various chronic and lifestyle disorders in women, and high prevalence of infectious diseases such as HIV and hepatitis in women across the globe are driving the growth of the market.

Get Sample Copy for more Professional and Technical insights @ https://www.marketsandmarkets.com/ResearchInsight/womens-health-diagnostics-market.asp

In this report, the global women health diagnostics market is segmented on the basis of application and end user. On the basis of application, the market is segmented into nine segments namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. The osteoporosis segment is further divided into bone densitometry and in vitro blood tests. The ovarian cancer segment is divided into tumor marker tests, diagnostic imaging tests and others. The cervical cancer segment is sub segmented into PAP smear testing and HPV testing.

Browse and in-depth TOC on "Women’s Health Diagnostics Market"
265 - Tables
37 - Figures
292 - Pages

Browse 265 market data tables and 37 figures spread through 292 pages and in-depth TOC on “Womens Health Diagnostics Market by application (Prenatal Testing, Down Syndrome, HPV, Fertility Test, Pregnancy Test, Urinary Tract Infections, Osteoporosis, Breast, Cervical and Ovarian Cancer Test) End User (Hospitals, Home Care) - Forecast to 2021”

https://www.marketsandmarkets.com/Market-Reports/womens-health-diagnostics-market-128928901.html

The global women health diagnostics market is segmented on the basis of application, end user, and region. On the basis of application, the market is segmented nine segments, namely, osteoporosis testing, ovarian cancer testing, cervical cancer testing, breast cancer testing, pregnancy & ovulation testing, prenatal genetic screening & carrier testing, infectious disease testing, sexually transmitted disease testing, and ultrasound. On the basis of end users, the women health diagnostics market is segmented into hospital & clinics, home healthcare, and diagnostic & imaging centers.

Geographically, the global market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. In 2015, North America commanded the largest share of the global women health diagnostics market. The major share of this region can be attributed to increasing prevalence of cancer among women in this region, increasing incidence of lifestyle related health disorders, growing focus of manufacturers of women’s health diagnostic products on expanding their presence in this region, and increasing demand for fertility testing monitors.

Make an Inquiry Prior To Purchase this research study @https://www.marketsandmarkets.com/PressReleases/womens-health-diagnostics.asp